Hedge Fund Drops Million in Crinetics: Is It a Buy?
A major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
Guidance on practical actions in your 30s to set up a strong retirement, including saving, debt management, and early investment habits.
16,695 articlesA major hedge fund just disclosed a multi-million stake in Crinetics, a rare-disease biotech. This article unpacks wh...
When insiders move stock, investors pay attention. This article breaks down what iradimed’s founder sold 7,500 means ...
If the market sinks tomorrow, one AI stock stands out as a compelling buy due to a durable moat, strong cash flow, an...
Broadcom posted solid revenue growth and a solid EPS beat, but AI chip guidance disappointed some. This guide breaks ...
Think AI stocks can’t deliver both growth and income? This piece reveals two surprising dividend plays that tap AI tr...
Schwab U.S. Dividend Equity ETF SCHD has moved to a more top-heavy stance, with the top 10 holdings nearing 41% of as...
A bold claim about a $22.7 trillion enterprise AI opportunity could reshape portfolios. This piece breaks down the th...
SpaceX stock shines in the headlines, but the math behind the hype isn’t adding up for me. Here are four practical re...
As AI chip fears rattled markets, microsoft stock rose today thanks to cloud momentum, AI software adoption, and stro...
If you’re weighing big tech bets, Microsoft often outshines Apple on value. This guide breaks down why MSFT stands as...
A Nashville case highlights a troubling form of elder financial exploitation. Learn how scams work, the signs to watc...
A new Samsung-deepseek partnership is stirring the AI hardware scene. This guide breaks down what DeepSeek could mean...